Searched for
NARAYANA MURTHY PORTFOLIO
Infosys weighs CEO change; Groww's Lalit Keshre on next growth betsHappy Wednesday! Infosys is set to discuss CEO Salil Parekh's tenure and a succession roadmap as it reports Q4 results. This and more in to...
Cos can't run sweat shops, force employees to work extra: Karnataka IT Minister on 70-hours suggestionKarnataka IT Minister Priyank Kharge has expressed his stance on Narayana Murthy's recent statement regarding working hours. Kharge believe...
Nandan and Salil have not consulted me on any decision since 2017 and I do not expect them to: NR Narayana Murthy"Whatever principle I adopted, that should not have come in the way of legitimate opportunity for any youngster, forget about sons, daughte...
Every downturn a boon for Indian software companies: Narayana MurthyI think every downturn is actually a boom for Indian software companies except some extraordinary events like 2008 when the banking sector ...
Indian economy strongest in 300 years, investor confidence at historic high: Narayana MurthyMurthy said patriotism implies working for the country, putting its interests ahead of one's personal interests.
IT Employees Unions pitch for 'compassionate unionism'The IT employees associations today sought to allay fears of Infosys founder NR Narayana Murthy towards trade unionism.
R Seshasayee, Vishal Sikka play down Infosys dispute, defend corporate policiesThe Infosys board chairman and the chief executive maintained that the corporate governance tiff between founders and board members was ‘no...
Have a heartfelt, warm relationship with Narayana Murthy: Vishal SikkaDescribing Murthy as an "incredible man", Sikka said the two usually discussed topics like quantum physics and technology whenever they met.
Infosys shares dip over 2% post Annual General MeetingThe blue-chip stock declined by 2.27 per cent to settle at Rs 1,001.15 on the BSE. During the day, it lost 2.46 per cent to Rs 999.10.
Founders fully committed to management, it's all good: Infosys CEO Vishal SikkaInfosys CEO Vishal Sikka said the founders of India's second largest IT services firm Infosys still remain committed to the firm and the so...
Narayana Murthy invests in realty, Azim Premji to follow suitInfosys co-founder NR Narayana Murthy's family office has bought high-end luxury apartments in Bangalore and Mumbai, said sources familiar ...
Balakrishnan's exit: Infosys' potential CEO's exit follows raft of top-deck resignations since NRN's returnThe man regarded as potential successor to CEO SD Shibulal has joined the parade of senior executives leaving Infy, adding to the impressio...
Infosys may see major changes in the organization structure soonInfosys is preparing the ground for major changes in its organisational structure as Murthy implements his plan to revive the company.
Infosys' V Balakrishnan gets bigger role, replaces BG Srinivas as Lodestone chairmanInfosys confirmed that Balakrishnan replaced Srinivas recently, but denied any challenges at Lodestone, which it bought in September for $3...
Top five brokerage firms’ views on InfosysAccording to the brokerages, the return of Narayana Murthy to an executive role after 7 years may boost investors’ confidence in the compan...
Top ten brokerage views on Infosys post Murthy's comebackAnalysts at top brokerage firms are positive on Infosys as appointment of Narayana Murthy as EC is likely to turn things around.
Catamaran likely to sail slow as NR Narayana Murthy spends more time with 'middle child' InfosysMurthy acknowledged that Catamaran may have to make some sacrifices as he prepares to spend more time at the company he founded in 1981.
- Narayana Murthy's Cataraman to have a wide portfolio
Murthy has formed a Rs 600 crore venture capital fund -- Catamaran Investment Pvt Ltd, to help incubate start-ups in the country. New teen ...
- Murthy's Cataraman to be sector-agnostic while investing
Infosys Chief Mentor N R Narayana Murthy said the venture capital fund set up by him will have a wide portfolio and not focus on any partic...
- Biocon forays into nephrology space
The new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category.